Drug Information Related to Levoleucovorin
01. New Drug Application Filing for Levoleucovorin Tablets Completed by .....
* NDA for Levoleucovorin for Injection Was Approved by the FDA on
March 7(th), 2008
* Spectrum Plans to Launch Levoleucovorin for Injection in the
Third Quarter 2008, as Soon as the FDA Approves Its Trade Name
IRVINE, Calif. -- Spectrum Pharmaceuticals, Inc....
02. Spectrum Pharmaceuticals Announces FUSILEV(TM) as Tradename for ......
* FUSILEV[TM] Launch Expected in Mid-August 2008
* FUSILEV[TM] NDA Approved by the FDA On March 7th, 2008
IRVINE, Calif. -- Spectrum Pharmaceuticals, Inc., (NasdaqGM: SPPI)
today announced the selection of FUSILEV[TM] (levoleucovorin) for
injection as the tr...
03. CDC Software's Warehouse Management Solution Helps Schneider Electric ...
Leading Supplier of Electrical Distribution and Automation Control
Products Goes Live on Latest Release of cWMS on Time and under Budget
LONDON & HONG KONG -- CDC Software, a wholly owned subsidiary
of CDC Corporation (NASDAQ: CHINA) and a provider of indus...
04. Spectrum Pharmaceuticals Announces First Quarter 2008 Financial Result...
* Approximately $48.6 Million Cash and Equivalents as of March 31, 2008
...
05. Allergan Passes Pfizer Acquisition Test, Analyst Says | Orange County ...
Valeant Upbeat on Liver Drug, Analyst Unfazed; Spectrum Bone Cancer Drug Gets FDA OK
...
06. Pipeline | Medical Marketing and Media | Find Articles at BNET.com...
The FDA approved AstraZeneca's Nexium for short-term use in children ages one-11 years old for the treatment of GERD. The agency approved Nexium in two forms: a delayed-release capsule and liquid form. Nexium is approved in 10 mg or 20 mg daily for children 1-11 years o...